Complex Bioengineering for Cell Therapies Summit

Start: Wednesday, November 13, 2024 8:00AM
End: Thursday, November 14, 2024 4:00PM

The Complex Bioengineering for Cell Therapies Summit is the premier event for bioengineering experts. Explore cutting-edge technologies and platforms driving the next generation of cell therapies, with a unique focus on the intricate molecular biology of the TME and advanced design and delivery technologies.

With increasing FDA scrutiny on CAR-T therapies and challenges with solid tumors, this event is timely and essential. Connect with top experts from A2 Biotherapeutics, Bristol Myers Squibb, Senti Biosciences, and more. Engage in strategic discussions and see technology showcases that will drive your cell therapy products forward.

This November is your opportunity to lead in a rapidly evolving field. A chance to be at the forefront of therapeutic advancements in cell therapy!

Explore The Full Agenda - https://ter.li/bnyorf
Secure Our Highest Savings - https://ter.li/qvqsay

URLs:
Tickets: https://go.evvnt.com/2609907-2?pid=3698
Brochure: https://go.evvnt.com/2609907-3?pid=3698

Prices:
Conference Pass - Drug Developer Pricing: USD 2999.00,
Conference Pass - Start Up/Academic Pricing: USD 2599.00,
Conference Pass - Standard/Vendor Pricing: USD 3699.00

Speakers: Amish Patel | Senior Vice President, Technical Operations | Calidi Biotherapeutics Inc., Cheng Liu | President and Chief Executive Officer | Eureka Therapeutics, Eduardo Laborda | Director, Immuno-Oncology | Calibr-Skaggs at Scripps Research, Elena Peletskaya | Senior Director, Portfolio Technical Strategy | Bristol Myers Squibb, Eytan Breman | Head of Research and Development | Celyad Oncology, Gary Shapiro | Vice President, Discovery Biology | Affini-T Therapeutics, Henri Bayle | Chief Scientific Officer | NKILT Therapeutics, Hugh Gannon | Associate Director | KSQ Therapeautics, John Rossi | Vice President of Translational Medicine | Capstan Therapeutics, Julia Coronella | Vice President of Immuno-Oncology | Poseida Therapeutics, Junchen Gu | Associate Director | AstraZeneca, Leticia Tordesillas | Research Scientist, | Moffitt Cancer Center, Nicholas Frankel | Associate Director-Gene Circuit Discovery | Senti Biosciences Inc., Ron Weiss | Professor | Massachusetts Institute of Technology, Salman Punekar | Medical Oncologist | NYU Langone Health, Perlmutter Cancer Center, Sanam Shafaattalab | Scientist II | A2 Biotherapeutics, Yang Claire Zeng | Founder and CEO | DoriNano